FAM
SAGE icon

Fortaleza Asset Management’s Sage Therapeutics SAGE Stock Holding History

Fortaleza Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$110K Sell
700
-315
-31% -$49.5K 0.89% 59
2018
Q1 		$163K Hold
1,015
– – 0.99% 51
2017
Q4 		$167K Buy
+1,015
New +$98.4K 1.05% 48

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OppenheimerFunds
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fortaleza Asset Management's SAGE Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Sage Therapeutics (SAGE) stake by 31% in Q2 2018, selling an estimated $49.5K and leaving 700 shares worth $110K. The position accounts for 0.89% of the portfolio, ranked #59.

Fortaleza Asset Management first reported a position in SAGE in Q4 2017 and has held it in 3 quarters since. The position peaked at $167K in Q4 2017. 269 funds tracked by Wall St. Rank hold SAGE as of Q2 2018.

  • Fortaleza Asset Management held 700 shares of Sage Therapeutics worth $110K as of Q2 2018.
  • Fortaleza Asset Management sold 315 Sage Therapeutics shares in Q2 2018, an estimated $49.5K.
  • Sage Therapeutics made up 0.89% of Fortaleza Asset Management's portfolio in Q2 2018, its #59 holding.
  • Fortaleza Asset Management first reported a position in Sage Therapeutics in Q4 2017 and has held it in 3 quarters since.
  • Fortaleza Asset Management's Sage Therapeutics position peaked at $167K in Q4 2017.
  • 269 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.